Effects of PEG in patients with esophageal squamous cell carcinoma during concurrent chemoradiotherapy: a prospective studyJie Dong, Qingsong Pang, Zhenbo Dai et al.|Gastrointestinal Endoscopy|2023Cited by 6
LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapyY. Zhang, Qingsong Pang, Ziyang Zhou et al.|Cancer Immunology Immunotherapy|2025Cited by 2
A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter studyYunsong Liu, Zhouguang Hui, Xinyun Song et al.|Radiotherapy and Oncology|2025Cited by 2